Greenwood Capital Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.75M | Buy |
12,861
+4,419
| +52% | +$2.32M | 0.84% | 32 |
|
|
2025
Q1 | $5.35M | Buy |
+8,442
| New | +$5.35M | 0.72% | 48 |
|
|
2020
Q4 | – | Sell |
-5,629
| Closed | -$3.15M | – | 211 |
|
|
2020
Q3 | $3.15M | Sell |
5,629
-70
| -1% | -$39.2K | 0.61% | 55 |
|
|
2020
Q2 | $3.55M | Sell |
5,699
-3,867
| -40% | -$2.41M | 0.81% | 47 |
|
|
2020
Q1 | $4.67M | Buy |
+9,566
| New | +$4.67M | 1.37% | 29 |
|
|
2019
Q2 | – | Sell |
-14,138
| Closed | -$5.81M | – | 197 |
|
|
2019
Q1 | $5.81M | Buy |
14,138
+956
| +7% | +$393K | 1.49% | 23 |
|
|
2018
Q4 | $4.92M | Buy |
+13,182
| New | +$4.92M | 1.29% | 31 |
|